Related Experiment Video
Updated: Aug 6, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Disruption of microhomology-mediated end joining in Ewing sarcoma
Shuhei Asada1, Guangli Zhu2, Jithma Prasad Abeykoon3
1Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Abstract:
Ewing sarcoma (EwS) is a group of bone and soft-tissue cancers in children and young adults. Because EwS cells have pronounced sensitivity to radiation and chemotherapy-induced DNA damage, the oncoprotein EWS-FLI1 is likely to be involved in DNA repair. Here, we demonstrate that EWS-FLI1 causes a defect in microhomology-mediated end joining (MMEJ) repair. EWSR1 is a splicing factor that promotes the faithful splicing of the POLQ pre-mRNA, required for the expression of Polθ, a critical protein in the MMEJ pathway. Expression of EWS-FLI1 or depletion of EWSR1 causes increased POLQ exon 25 skipping, decreased Polθ expression, impaired MMEJ, and enhanced cellular sensitivity to inhibitors of the Fanconi anemia (FA), homologous recombination (HR), or non-homologous end joining (NHEJ) pathways, through the mechanism of synthetic lethality. Correction of POLQ exon 25 skipping restored Polθ expression and MMEJ activity in EwS. Inhibitors of the FA, HR, or NHEJ pathways may therefore provide a targeted therapy for EwS patients.
Insights
Ewing sarcoma (EwS) cells show impaired DNA repair due to the EWS-FLI1 oncoprotein. This defect in microhomology-mediated end joining (MMEJ) DNA repair offers potential therapeutic targets for EwS treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Ewing sarcoma (EwS) is a pediatric bone and soft-tissue cancer.
- EwS cells are sensitive to DNA damaging agents, suggesting a role for DNA repair pathways.
- The EWS-FLI1 oncoprotein is implicated in EwS pathogenesis.
Purpose of the Study:
- To investigate the role of EWS-FLI1 in DNA repair mechanisms in Ewing sarcoma.
- To identify potential therapeutic vulnerabilities in EwS based on DNA repair defects.
Main Methods:
- Assessed microhomology-mediated end joining (MMEJ) repair activity in EwS cells.
- Investigated the effect of EWS-FLI1 expression and EWSR1 depletion on MMEJ.
- Analyzed POLQ pre-mRNA splicing and Polθ expression.
- Evaluated cellular sensitivity to DNA repair pathway inhibitors.
Main Results:
- EWS-FLI1 expression causes a defect in MMEJ DNA repair.
- EWS-FLI1 disrupts EWSR1-mediated splicing of POLQ, leading to reduced Polθ expression and impaired MMEJ.
- EwS cells exhibit synthetic lethality with inhibitors of Fanconi anemia (FA), homologous recombination (HR), or non-homologous end joining (NHEJ) pathways.
- Restoring POLQ splicing corrected MMEJ function in EwS cells.
Conclusions:
- EWS-FLI1 impairs MMEJ DNA repair in Ewing sarcoma by affecting POLQ splicing.
- Targeting FA, HR, or NHEJ pathways represents a potential therapeutic strategy for EwS.
- Understanding DNA repair defects in EwS can guide the development of novel cancer treatments.
Related Concept Videos
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair
Homologous Recombination
Fixing Double-strand Breaks
Nucleotide Excision Repair
